TBCA expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.684400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.538160E-01
Normal-vs-Stage2
7.606600E-01
Normal-vs-Stage3
7.651400E-01
Normal-vs-Stage4
4.011400E-01
Stage1-vs-Stage2
1.905650E-02
Stage1-vs-Stage3
1.082570E-01
Stage1-vs-Stage4
3.161600E-01
Stage2-vs-Stage3
3.940800E-01
Stage2-vs-Stage4
5.717800E-01
Stage3-vs-Stage4
3.709000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.330600E-01
Normal-vs-AfricanAmerican
8.346800E-01
Normal-vs-Asian
6.672400E-01
Caucasian-vs-AfricanAmerican
5.978800E-01
Caucasian-vs-Asian
1.531420E-01
AfricanAmerican-vs-Asian
4.314000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.221000E-01
Normal-vs-Female
6.885400E-01
Male-vs-Female
5.869000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.075600E-01
Normal-vs-Age(41-60Yrs)
4.477200E-01
Normal-vs-Age(61-80Yrs)
7.755400E-01
Normal-vs-Age(81-100Yrs)
1.614160E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.524800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.547800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.463400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.828800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.143400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.817400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.766600E-01
Normal-vs-Daily Drinker
3.814400E-01
Normal-vs-Weekly Drinker
9.713200E-01
Normal-vs-Occasional Drinker
5.241400E-01
Normal-vs-Social Drinker
7.228400E-01
Non Drinker-vs-Daily Drinker
5.113600E-02
Non Drinker-vs-Weekly Drinker
9.944800E-01
Non Drinker-vs-Occasional Drinker
1.267420E-01
Non Drinker-vs-Social Drinker
5.818200E-01
Daily Drinker-vs-Weekly Drinker
9.703500E-02
Daily Drinker-vs-Occasional Drinker
4.381200E-01
Daily Drinker-vs-Social Drinker
1.392030E-01
Weekly Drinker-vs-Occasional Drinker
1.323960E-01
Weekly Drinker-vs-Social Drinker
5.781200E-01
Occasional Drinker-vs-Social Drinker
1.809810E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.337000E-01
Normal-vs-Grade 2
1.285830E-01
Normal-vs-Grade 3
1.263160E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.980350E-01
Grade 1-vs-Grade 3
2.553600E-01
Grade 1-vs-Grade 4
4.337000E-01
Grade 2-vs-Grade 3
6.343400E-01
Grade 2-vs-Grade 4
1.285830E-01
Grade 3-vs-Grade 4
1.263160E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.901200E-01
Normal-vs-NonDiabetic
6.214800E-01
Diabetic-vs-NonDiabetic
1.521600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.348800E-01
Normal-vs-NoPancreatitis
6.591600E-01
Pancreatitis-vs-NoPancreatitis
8.092000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.755200E-01
Normal-vs-N1
7.436000E-01
N0-vs-N1
1.028190E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.782800E-01
Normal-vs-TP53-NonMutant
3.220800E-01
TP53-Mutant-vs-TP53-NonMutant
6.729400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
